[go: up one dir, main page]

CO4340623A1 - Derivados de indolina, metodo de preparacion y uso - Google Patents

Derivados de indolina, metodo de preparacion y uso

Info

Publication number
CO4340623A1
CO4340623A1 CO94057739A CO94057739A CO4340623A1 CO 4340623 A1 CO4340623 A1 CO 4340623A1 CO 94057739 A CO94057739 A CO 94057739A CO 94057739 A CO94057739 A CO 94057739A CO 4340623 A1 CO4340623 A1 CO 4340623A1
Authority
CO
Colombia
Prior art keywords
alkyl
same
hydrogen
indoline
derivatives
Prior art date
Application number
CO94057739A
Other languages
English (en)
Inventor
Peter Charles North
Malcolm Clive Carter
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of CO4340623A1 publication Critical patent/CO4340623A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

REIVINDICACION NUMERO UN COMPUESTO DE LA FORMULA (I) FIGURA 1 CARACTERIZADO PORQUE R1 ES HIDROGENO, HALOGENO O ALQUILO DE C1-6; R2 ES UN GRUPO DE LA FORMULA -CR3R4(CH2)pNR5COR6; R3, R4 y R5, LOS CUALES PUEDER SER IGUALES O DI- FERENTES, SON HIDROGENO O ALQUILO DE C1-6; R6 ES UN ALQUILO DE C1-6 O CICLOALQUILO DE C3-7; n ES UN NUMERO ENTERO DE 2, 3 o 4; p ES UN NUMERO ENTERO DE 1, 2, 3 o 4; Y SUS SALES Y SOLVATOS DEL MISMO, FARMACEUTICA- MENTE ACEPTABLES". REIVINDICACION NUMERO UN COMPUESTO DE LA FORMULA (Ia) FIGURA 2 CARACTERIZADO PORQUE R1 ES HIDROGENO, HALOGENO O ALQUILO DE C1-6; R2 ES UN GRUPO DE LA FORMULA -CR3R4(CH2)pNR5COR6; R3, R4 Y R5, LOS CUALES PUDEN SER IGUALES O DIFE- RENTES, SON HIDROGENO O ALQUILO DE C1-6; R6 ES ALQUILO DE C1-6 O CICLOALQUILO DE C3-7; p ES UN NUMERO ENTERO DE 1, 2, 3 o 4; Y SUS SALES Y SOLVATOS DEL MISMO, FARMACEUTICA- MENTE ACEPTABLES".
CO94057739A 1993-12-22 1994-12-21 Derivados de indolina, metodo de preparacion y uso CO4340623A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939326192A GB9326192D0 (en) 1993-12-22 1993-12-22 Chemical compounds

Publications (1)

Publication Number Publication Date
CO4340623A1 true CO4340623A1 (es) 1996-07-30

Family

ID=10747030

Family Applications (1)

Application Number Title Priority Date Filing Date
CO94057739A CO4340623A1 (es) 1993-12-22 1994-12-21 Derivados de indolina, metodo de preparacion y uso

Country Status (15)

Country Link
US (1) US5633276A (es)
EP (1) EP0736028A1 (es)
JP (1) JPH09507057A (es)
AP (1) AP535A (es)
AU (1) AU684877B2 (es)
CA (1) CA2179402A1 (es)
CO (1) CO4340623A1 (es)
GB (1) GB9326192D0 (es)
IL (1) IL112097A (es)
IS (1) IS4244A (es)
MY (1) MY131641A (es)
SV (1) SV1994000083A (es)
TW (1) TW291479B (es)
WO (1) WO1995017405A1 (es)
ZA (1) ZA9410056B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2741799B1 (fr) * 1995-12-04 1998-01-02 Oreal Utilisation de melatonine dans une composition pour traiter les signes cutanes des etats de fatigue
EP1199304A1 (en) * 1997-03-05 2002-04-24 Takeda Chemical Industries, Ltd. Bicyclic compounds and pharmaceutical composition containing tricyclic compound for treating or preventing sleep disorders
US6034239A (en) * 1996-03-08 2000-03-07 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
EP0885210B2 (en) * 1996-03-08 2008-06-18 Takeda Pharmaceutical Company Limited Tricylic compounds having binding affinity for melatonin receptors, their production and use
ZA9711051B (en) * 1996-12-10 1999-06-09 Bristol Myers Squibb Co Benzodioxole benzofuran dihydrobenzofuran and benzodioxane melatonergic agents
WO1998038991A1 (en) * 1997-03-05 1998-09-11 Bristol-Myers Squibb Company Polycyclic ethyl alkylamide melatonergic agents
FR2763335B1 (fr) * 1997-05-16 2000-11-24 Adir Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU727654B2 (en) * 1997-06-13 2000-12-21 Yamanouchi Pharmaceutical Co., Ltd. Tricyclic pyrazole derivative
AU740554B2 (en) * 1998-06-05 2001-11-08 Bristol-Myers Squibb Company Heterocyclic cis cyclopropane derivatives as melatonergic agents
EP1189900B1 (en) 1999-06-30 2004-01-14 Bristol-Myers Squibb Company Heterocyclic aminopyrrolidine derivatives as melatonergic agents
GB9918965D0 (en) * 1999-08-11 1999-10-13 Cerebrus Ltd Chemical compounds xxi
ATE293628T1 (de) 1999-08-20 2005-05-15 Takeda Pharmaceutical Dihydrobenzofuranderivate, verfahren zu ihrer herstellung und mittel
US7012090B1 (en) 2000-03-17 2006-03-14 Alcon, Inc. Pyranoindoles for treating glaucoma
DE60005566T2 (de) * 2000-03-17 2004-07-29 Alcon, Inc. Pyranoindole zur glaukombehandlung
ES2172415B2 (es) 2000-07-28 2003-11-16 Univ Madrid Complutense Tratamiento del glaucoma y la hipertension ocular por medio de un analogo de la melatonina.
WO2002055020A2 (en) * 2000-12-11 2002-07-18 Testocreme Llc Topical testosterone formulations and associated methods
WO2002079153A1 (en) * 2001-03-28 2002-10-10 Biocatalytics, Inc. Method for producing tryptamine derivatives
PE20080122A1 (es) * 2006-03-20 2008-04-24 Takeda Pharmaceutical Agente profilactico o terapeutico para el sindrome de colon irritable
US8273761B2 (en) * 2006-12-08 2012-09-25 Takeda Pharmaceutical Company Limited Tricyclic compound and medical use thereof
ES2331274B1 (es) * 2007-10-25 2010-10-21 Ferrer Internacional, S.A. Compuesto de indolina.
JP2011529477A (ja) 2008-07-30 2011-12-08 フエルレル インターナショナル，ソシエダッド アノニマ １，６−ジヒドロ−２ｈ−３−オキサ−６−アザ−ａｓ−インダセン化合物
BR102016024814A2 (pt) 2016-10-24 2018-05-08 Aché Laboratórios Farmacêuticos S.A. composto, processo de obtenção do composto, composição farmacêutica, uso do composto e método de tratamento de desordens psiquiátricas e/ou distúrbios do sono

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2485539A1 (fr) * 1980-06-26 1981-12-31 Sori Soc Rech Ind Nouveau derive de pyranno-indole, son procede de preparation et son application en therapeutique
US4703052A (en) * 1985-05-21 1987-10-27 Pfizer Inc. Hypoglycemic thiazolidinediones
US4738972A (en) * 1985-05-21 1988-04-19 Pfizer Inc. Hypoglycemic thiazolidinediones

Also Published As

Publication number Publication date
IS4244A (is) 1995-06-23
AP9400706A0 (en) 1995-01-31
IL112097A0 (en) 1995-03-15
US5633276A (en) 1997-05-27
MY131641A (en) 2007-08-30
ZA9410056B (en) 1995-10-18
CA2179402A1 (en) 1995-06-29
GB9326192D0 (en) 1994-02-23
IL112097A (en) 1998-06-15
EP0736028A1 (en) 1996-10-09
WO1995017405A1 (en) 1995-06-29
AP535A (en) 1996-09-16
SV1994000083A (es) 1995-07-24
TW291479B (es) 1996-11-21
AU684877B2 (en) 1998-01-08
AU1274395A (en) 1995-07-10
JPH09507057A (ja) 1997-07-15

Similar Documents

Publication Publication Date Title
CO4340623A1 (es) Derivados de indolina, metodo de preparacion y uso
ES520300A0 (es) Procedimiento para la obtencion de 1,4-dihidropiridinas.
ES2065133T3 (es) Derivados de piperazina.
ATE31307T1 (de) Benzofuran- und benzopyrancarboxamid-derivate.
CO4410331A1 (es) Derivados triciclicos del pirazol
ES2165516T3 (es) Feniloxazolidinonas con un enlace c-c con anillos heterociclicos de 4-8 miembros.
ES2193137T3 (es) Heteroaril aminas como nuevos inhibidors de acetilcolinesterasa.
PL295030A1 (en) Method of obtaining substituted derivatives of 2-cyclohexan-1-yl amine
ES2159749T3 (es) Derivados de bencilamino-2-metil-propanamidas 2-(4-sustituidas).
DE69525354D1 (de) Eine neuartige medizinische verwendung eines 5ht 3-antagonisten
CO4370018A1 (es) Derivados de naftaleno, metodo de preparacion y uso
IL106387A (en) Indole derivatives, their preparation and pharmaceutical compositions containing them
ES2104794T3 (es) 3-isoxazolilfenil-compuestos, su obtencion y su empleo.
SE8505887L (sv) Indoler
UY24010A1 (es) Nuevos pirrolocarbazoles
ES2125161B1 (es) Nuevos derivados de 2-(3h)-oxazolona.
ES2141763T3 (es) Fenilcarbonatos y fenilureas sustituidos, su preparacion y su uso como antagonistas de 5-ht4.
ATE115136T1 (de) 4-phenylphthalazin-derivate.
ES2108595B1 (es) Derivados de la 3(2h)-piridacinona y procedimiento para su preparacion.
AR246851A1 (es) Composicion herbicida.
ES2071479T3 (es) Derivados de indano.
ES2063831T3 (es) Derivados de 4,5,6,7-tetrahidrobencimidazol y su preparacion.
ES2073460T3 (es) Fenilalquilaminas y los fungicidas que las contienen.
ES2143630T3 (es) Derivados azabicicloalquilos de imidazo(1,5-a)indol-3-ona utilizados como antagonistas de 5ht3.
ES2142817T3 (es) Compuestos triciclicos como antagonistas de la angiotensina ii.